Home › Anorexia Nervosa › NCT04810624
Relapse Prevention and Changing Habits in Anorexia Nervosa
Optimizing Relapse Prevention and Changing Habits in Anorexia Nervosa
Who can join
Ages 18 to 60 · All sexes
Full eligibility criteria
Inclusion Criteria: * Diagnosis of Anorexia Nervosa at hospital admission * Medically Stable * Internet capability with videoconferencing * Weight restored (BMI \> 19 kg/m2) at New York State Psychiatric Institute Exclusion Criteria: * Current substance use or other comorbid disorder requiring specialized treatment * Pregnancy * Imminent risk of suicide * Serious medical illness * Daily psychotropic medication other than antidepressants (medications that are known effect weight are exclusionary, i.e. stimulants, olanzapine, mirtazapine) * Participation in outside psychotherapy or structured treatment program (support groups will be allowed). Individuals who are discharged on medications would need to have a non-study psychiatrist.
About the study
This study aims to optimize a treatment package for the relapse prevention treatment of AN. In the Preparation Phase, we examined accessibility and feasibility of the treatment package.
In the current Optimization Phase, we will identify which components of treatment contribute to positive outcomes after acute hospitalization. We will carefully evaluate maintenance of remission, measured by rate of weight loss and end-of-trial status.
What is being tested
- Relapse Prevention and Changing Habits (REACH+) (behavioral)
Sponsor: New York State Psychiatric Institute · Participants: 60 · Started: Jun 21, 2021
Contact the study team
- Joanna Steinglass, MD · Phone: 646-774-6345
Official record on ClinicalTrials.gov — NCT04810624
Locations in the U.S.
| New York | New York State Psychiatric Institute, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.